An improved therapy is described for patients suffering from pathological
conditions characterized by viral, fungal, bacterial, or protozoal load
by which such load is reduced. The invention also alleviates symptoms
associated with such pathogen-load-characterized conditions by decreasing
the pathogen load.The present invention accomplishes those objects by
administering substances to patients suffering from pathogen load that
enhance the function of the patients' immune systems. The substances are
known as "immunoamplifiers," a term that refers to the substances'
ability to increase cell-mediated immune system response
non-specifically.